LVAD Destination Therapy: Applying What We Know About Psychiatric Evaluation and Management from Cardiac Failure and Transplant

Overview

Journal Heart Fail Rev

Date 2008 Jan 25

PMID 18214674

Citations 15

Authors

Anne K Eshelman

Shawn Mason

Hassan Nemeh

Celeste Williams

Affiliations

Soon will be listed here.

Abstract

Left ventricular assist devices (LVADs) have evolved into long-term use as destination therapy for those with severe end-stage heart failure due to other medical risks. Success with LVAD depends on adherence to a complicated mechanical regimen, and acceptance of a life that is far from normal. Patients with LVADs share characteristics with other end-stage cardiac failure patients and those waiting for or receiving heart transplants. Understanding the more thoroughly studied issues of psychiatric disorders, adherence, and behavioral correlates of success in heart failure and transplantation may identify feasible strategies for optimizing care of LVAD patients and suggest directions for future research. Depression and distress complicate post-transplant care. Psychiatric morbidity is associated with poor outcomes, including graft rejection, non-adherence, hospitalizations, infection, and death. With a high risk of embolic neurological events, patients' ability for self-care may be compromised. Psychiatric symptoms are underdiagnosed and undertreated, which may impact overall survival and quality of life.

Citing Articles

Why Is Social Reintegration Support for Patients With Left Ventricular Assist Device Necessary?.

Inoue T, Sakanaka N, Ota M, Noma T, Yamashita Y, Horii T Circ Rep. 2025; 7(3):147-153.

PMID: 40066215 PMC: 11890288. DOI: 10.1253/circrep.CR-25-0004.

The experience of bodily image for patients with left ventricular assist device.

Milaniak I, Witkowska E, Cebula M, Tomsia P, Wasilewski G, Gorkiewicz-Kot I Front Psychiatry. 2025; 15:1484428.

PMID: 39931192 PMC: 11808206. DOI: 10.3389/fpsyt.2024.1484428.

Curricular Self-management for patients on ventricular assist device support decreases depression: A multicenter randomized controlled trial.

Kugler C, Spielmann H, Richter F, Lauenroth V, Semmig-Konze S, Spitz-Koberich C Artif Organs. 2024; 49(3):373-389.

PMID: 39625121 PMC: 11848963. DOI: 10.1111/aor.14918.

Outcomes of patients with cardiac amyloidosis undergoing percutaneous left atrial appendage occlusion.

Agarwal S, Banthiya S, Bansal A, Munir M, DeSimone C, Deshmukh A J Interv Card Electrophysiol. 2024; 67(7):1657-1665.

PMID: 38822955 DOI: 10.1007/s10840-024-01843-6.

Perceptions of Bedside Nurses Caring for Patients with Left Ventricular Assist Devices (LVAD): A Qualitative Study.

El Zein S, Fawaz M, Al-Shloul M, Rayan A, ALBashtawy M, Abu Khader I SAGE Open Nurs. 2024; 10:23779608241252249.

PMID: 38746075 PMC: 11092549. DOI: 10.1177/23779608241252249.

References

Potapov E, Jurmann M, Drews T, Pasic M, Loebe M, Weng Y . Patients supported for over 4 years with left ventricular assist devices. Eur J Heart Fail. 2006; 8(7):756-9. DOI: 10.1016/j.ejheart.2006.02.003. View

Lazar R, Shapiro P, Jaski B, Parides M, Bourge R, Watson J . Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation. 2004; 109(20):2423-7. DOI: 10.1161/01.CIR.0000129414.95137.CD. View

Grady K, Meyer P, Mattea A, White-Williams C, Ormaza S, Kaan A . Improvement in quality of life outcomes 2 weeks after left ventricular assist device implantation. J Heart Lung Transplant. 2001; 20(6):657-69. DOI: 10.1016/s1053-2498(01)00253-4. View

Bunzel B, Laederach-Hofmann K, Wieselthaler G, Roethy W, Drees G . Posttraumatic stress disorder after implantation of a mechanical assist device followed by heart transplantation: evaluation of patients and partners. Transplant Proc. 2005; 37(2):1365-8. DOI: 10.1016/j.transproceed.2004.12.248. View

Moskowitz A, Weinberg A, Oz M, Williams D . Quality of life with an implanted left ventricular assist device. Ann Thorac Surg. 1998; 64(6):1764-9. DOI: 10.1016/s0003-4975(97)01000-x. View

Dew M, Kormos R, Winowich S, Harris R, Stanford E, Carozza L . Quality of life outcomes after heart transplantation in individuals bridged to transplant with ventricular assist devices. J Heart Lung Transplant. 2001; 20(11):1199-212. DOI: 10.1016/s1053-2498(01)00333-3. View

Dew M, DiMartini A . Psychological disorders and distress after adult cardiothoracic transplantation. J Cardiovasc Nurs. 2005; 20(5 Suppl):S51-66. DOI: 10.1097/00005082-200509001-00007. View

Cupples S, Stilley C . Cognitive function in adult cardiothoracic transplant candidates and recipients. J Cardiovasc Nurs. 2005; 20(5 Suppl):S74-87. DOI: 10.1097/00005082-200509001-00009. View

Gordon R, Quagliarello B, Lowy F . Ventricular assist device-related infections. Lancet Infect Dis. 2006; 6(7):426-37. DOI: 10.1016/S1473-3099(06)70522-9. View

10.

Cupples S, Dew M, Grady K, de Geest S, Dobbels F, Lanuza D . Report of the Psychosocial Outcomes Workgroup of the Nursing and Social Sciences Council of the International Society for Heart and Lung Transplantation: present status of research on psychosocial outcomes in cardiothoracic transplantation: review.... J Heart Lung Transplant. 2006; 25(6):716-25. DOI: 10.1016/j.healun.2006.02.005. View

11.

Petrucci R, Truesdell K, Carter A, Goldstein N, Russell M, Dilkes D . Cognitive dysfunction in advanced heart failure and prospective cardiac assist device patients. Ann Thorac Surg. 2006; 81(5):1738-44. DOI: 10.1016/j.athoracsur.2005.12.010. View

12.

Grady K, Meyer P, Dressler D, Mattea A, Chillcott S, Loo A . Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation. Ann Thorac Surg. 2004; 77(4):1321-7. DOI: 10.1016/j.athoracsur.2003.09.089. View

13.

Lee H, Jayaram G, Teitelbaum M . Electroconvulsive therapy for depression in a cardiac transplant patient. Psychosomatics. 2001; 42(4):362-4. DOI: 10.1176/appi.psy.42.4.362. View

14.

Konstam V, Moser D, De Jong M . Depression and anxiety in heart failure. J Card Fail. 2005; 11(6):455-63. DOI: 10.1016/j.cardfail.2005.03.006. View

15.

Pae W, Connell J, Boehmer J, Korfer R, El-Banayosy A, Hetzer R . Neurologic events with a totally implantable left ventricular assist device: European LionHeart Clinical Utility Baseline Study (CUBS). J Heart Lung Transplant. 2007; 26(1):1-8. DOI: 10.1016/j.healun.2006.10.007. View

16.

Miller L, Lietz K . Candidate selection for long-term left ventricular assist device therapy for refractory heart failure. J Heart Lung Transplant. 2006; 25(7):756-64. DOI: 10.1016/j.healun.2006.03.007. View

17.

Taylor D, Edwards L, Boucek M, Trulock E, Keck B, Hertz M . The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report--2004. J Heart Lung Transplant. 2004; 23(7):796-803. DOI: 10.1016/j.healun.2004.05.004. View

18.

Park S, Tector A, Piccioni W, Raines E, Gelijns A, Moskowitz A . Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg. 2005; 129(1):9-17. DOI: 10.1016/j.jtcvs.2004.04.044. View

19.

Selzman C, Oberlander J . The price of progress: destination left ventricular assist device therapy for terminal heart failure. N C Med J. 2006; 67(2):116-7. View

20.

de Geest S, Dobbels F, Fluri C, Paris W, Troosters T . Adherence to the therapeutic regimen in heart, lung, and heart-lung transplant recipients. J Cardiovasc Nurs. 2005; 20(5 Suppl):S88-98. DOI: 10.1097/00005082-200509001-00010. View